EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $21,928,000 | -23.4% | 437,951 | -3.6% | 0.08% | -21.2% |
| Q2 2021 | $28,623,000 | -31.9% | 454,405 | +0.4% | 0.10% | -33.6% |
| Q1 2021 | $42,051,000 | +5.0% | 452,597 | +1.3% | 0.15% | +3.5% |
| Q4 2020 | $40,050,000 | -11.3% | 446,984 | +2.3% | 0.14% | -22.6% |
| Q3 2020 | $45,152,000 | -13.6% | 436,969 | -33.9% | 0.19% | -15.8% |
| Q2 2020 | $52,260,000 | +25.4% | 660,852 | -8.3% | 0.22% | +1.4% |
| Q1 2020 | $41,676,000 | +32.8% | 720,284 | +23.9% | 0.22% | +67.7% |
| Q4 2019 | $31,371,000 | -0.1% | 581,480 | -3.2% | 0.13% | -4.4% |
| Q3 2019 | $31,397,000 | +26.9% | 600,563 | +17.2% | 0.14% | +22.5% |
| Q2 2019 | $24,747,000 | +4.8% | 512,257 | +9.6% | 0.11% | -1.8% |
| Q1 2019 | $23,616,000 | +51.7% | 467,468 | +78.0% | 0.11% | +31.4% |
| Q4 2018 | $15,571,000 | – | 262,661 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |